Hospitalizations are on the rise in 17 states, even as 42% of American adults have received at least one dose of a vaccine.
- US has now surpassed more than 560,000 deaths from COVID-19 according to Johns Hopkins University. This as vaccinations continue to ramp up all of this. While Johnson & Johnson warns about a drop in the supply of its vaccine next week. With the nation's COVID death toll now surpassing 560,000, health experts are cautioning about the uptick in cases among younger unvaccinated Americans.
DR. ASHISH JHA: Seeing young people get hospitalized and some of them even get really sick and die. So we have to be very careful in the weeks ahead.
- Hospitalizations are on the rise in 17 states, even as 42% of American adults have received at least one dose of a vaccine. And now states are bracing for a drop in supply of the Johnson & Johnson vaccine.
- There are available appointments now. They're probably not going to be available next week.
- Available doses of Johnson & Johnson expected to drop nearly 85% from around 5 million this week. 785,000 next week. The governor of Illinois blaming a mix up of ingredients at a Baltimore plant that ruined millions of doses, yet to be sent out.
GOV. J.B. PRITZKER: 15 million doses would have been distributed over some time to the states and those are lost.
- Federal officials insist it won't affect overall distribution goals this after vaccination sites in North Carolina and Colorado, temporarily stopped giving Johnson & Johnson shots after a small number of people had adverse reactions. Health experts say, side effects are normal and insist the vaccines are safe.
DR. IMRAN ALI: And these were very mild adverse reactions. And the CDC actually came out with a statement in the evening saying that the vaccinations should resume.
- Many new study finds people who got Moderna vaccine reported more side effects than those who got the Pfizer shot. Moderna recipients were more likely to report getting the chills and other side effects, including fever and fatigue.